Researching: Ozempic
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Ozempic"...
RxInsider Coverage (4)
Money
Lilly’s Mounjaro Pricing Strategy: Gross-to-Net Math Behind Market Dominance
Mar 6
Data
NADAC Price Trends: The Drug Categories Moving Most This Quarter
Feb 24
The Week
Weekly Pharma Roundup: Merck's $11B Bet, FDA Pushback, and Earnings Surprises
Feb 21
Pipeline
Late-Stage Obesity Drugs Beyond GLP-1s: Orforglipron, Survodutide, and the Oral Alternatives That Could Reshape Pricing
Feb 18
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.